Inventories

The following table presents our inventories of ADCETRIS (in thousands):



	September 30, 2018		December 31, 2017
Raw materials	$	60,819	$	52,398
Finished goods	14,353		7,580
Total	$	75,172	$	59,978

We capitalize ADCETRIS inventory costs. ADCETRIS inventory that is deployed into clinical, research or development use is charged to research and development expense when it is no longer available for use in commercial sales. We do not capitalize manufacturing costs for any of our product candidates.